P
Parabilis Medicines, Inc.
PBLS · NASDAQ · Healthcare · 4.3B
Price · close
$39.36
-0.56% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
—
Enterprise value / EBITDAEV/EBITDA
-0.5×
Free cash flow yieldFCF yield
-306.5%
Return on equityROE
882.9%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
-0.2×
Interest coverage
-99.9×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.